BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17674378)

  • 1. Utility of thoracic sonography for follow-up examination of chronic heart failure patients with previous decompensation.
    Kataoka H
    Clin Cardiol; 2007 Jul; 30(7):336-41. PubMed ID: 17674378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound pleural effusion sign as a useful marker for identifying heart failure worsening in established heart failure patients during follow-up.
    Kataoka H
    Congest Heart Fail; 2012; 18(5):272-7. PubMed ID: 22994441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of body fluid status to B-type natriuretic peptide levels in patients with chronic heart failure during long-term follow-up.
    Kataoka H
    Clin Cardiol; 2006 Oct; 29(10):457-61. PubMed ID: 17063950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure.
    Davutoglu V; Yildirim C; Kucukaslan H; Yuce M; Sari I; Tarakcioglu M; Akcay M; Cakici M; Ceylan N; Al B
    Kardiol Pol; 2010 Jul; 68(7):771-8. PubMed ID: 20648434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum level of tumor marker carbohydrate antigen-CA125 in heart failure.
    Durak-Nalbantic A; Resic N; Kulic M; Pecar E; Zvizdic F; Dzubur A; Dilic M; Gojak R; Sokolovic S; Hodzic E; Brdjanovic S
    Med Arch; 2013; 67(4):241-4. PubMed ID: 24520743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of thoracic ultrasonography for evaluation of patients with decompensated chronic heart failure.
    Kataoka H; Takada S
    J Am Coll Cardiol; 2000 May; 35(6):1638-46. PubMed ID: 10807471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
    Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
    PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure.
    Porcel JM; Bielsa S; Morales-Rull JL; Civit C; Cao G; Light RW; Esquerda A
    Respirology; 2013 Apr; 18(3):540-5. PubMed ID: 23278975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of plasma brain natriuretic peptide, urea nitrogen, and creatinine in outpatients >70 years of age with heart failure.
    Feola M; Aspromonte N; Canali C; Ceci V; Giovinazzo P; Milani L; Quarta G; Ricci R; Scardovi AB; Uslenghi E; Valle R
    Am J Cardiol; 2005 Sep; 96(5):705-9. PubMed ID: 16125500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
    Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
    Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of tissue Doppler echocardiography in the diagnosis of new-onset congestive heart failure in patients with levels of B-type natriuretic peptide in the midrange and normal left ventricular ejection fraction.
    Arques S; Roux E; Sbragia P; Pieri B; Gelisse R; Ambrosi P; Luccioni R
    Echocardiography; 2006 Sep; 23(8):627-34. PubMed ID: 16970713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
    Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
    Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study.
    Morbach C; Buck T; Rost C; Peter S; Günther S; Störk S; Prettin C; Erbel R; Ertl G; Angermann CE;
    Clin Res Cardiol; 2018 Feb; 107(2):95-107. PubMed ID: 29143161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleural Fluid B-Type Natriuretic Peptide Level as an Additional Indicator for the Fluid's Etiology.
    Zalts R; Twizer T; Leiba R; Karban A
    Isr Med Assoc J; 2018 May; 20(5):304-307. PubMed ID: 29761677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of heart failure in pleural fluid.
    Porcel JM; Martínez-Alonso M; Cao G; Bielsa S; Sopena A; Esquerda A
    Chest; 2009 Sep; 136(3):671-677. PubMed ID: 19363209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure.
    Di Marca S; Rando A; Cataudella E; Pulvirenti A; Alaimo S; Terranova V; Corriere T; Pisano M; Di Quattro R; Ronsisvalle ML; Giraffa CM; Giordano M; Stancanelli B; Malatino L
    Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):636-642. PubMed ID: 29625779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide and impedance cardiography at the time of routine echocardiography predict subsequent heart failure events.
    Castellanos LR; Bhalla V; Isakson S; Daniels LB; Bhalla MA; Lin JP; Clopton P; Gardetto N; Hoshino M; Chiu A; Fitzgerald R; Maisel AS
    J Card Fail; 2009 Feb; 15(1):41-7. PubMed ID: 19181293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.